circRNA basic information
circBase ID: -
Name: hsa_circ_ACAP2
Synonym: CircRNA_ACAP2
Host Gene: ACAP2
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0010150
MONDO name: head and neck squamous cell carcinoma
Disease details: head and neck squamous cell carcinoma
Disease DO ID:
5520
Disease MeSH ID:
C535575
Disease NCIt ID:
C34447
Disease ICD11 ID:
-
Disease OMIM ID:
275355
Species: Human
Species details: Homo sapiens
Tissue specimen:

HNSCC tissues; adjacent noncancerous tissue samples

Cell lines:

HN-4; HN-9; HN-30; SCC-4; SCC-9; SCC-25; CAL-27

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: STAT3, ZEB1
Associated microRNA: miR-21-5p
Biological function: Tumor suppressor in HNSCC; inhibits proliferation; suppresses migration and invasion; suppresses EMT
Molecular mechanism: CircRNA_ACAP2 sponges miR-21-5p and modulates STAT3 signaling (including STAT3 phosphorylation) and downstream ZEB1 to regulate EMT
Biological pathway or process:

EMT (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; FISH / smFISH; Luciferase Reporter Assay; Transfection; CCK8; Wound Healing Assay; Western Blot; IHC (Immunohistochemistry); Clinical Sample Validation; Cohort Study; Survival Analysis; Bioinformatics Analysis

Clinical significance:

Higher CircRNA_ACAP2 expression (positive group) is associated with better overall survival in HNSCC patients

Description:

CircRNA_ACAP2 is down-regulated in HNSCC and acts as a tumor suppressor. It primarily localizes to the cytoplasm and inhibits EMT-related behaviors (proliferation, migration/invasion) by sponging miR-21-5p to modulate STAT3 signaling and downstream ZEB1, and higher expression is associated with better overall survival.

Confidence score:

0.7696

Other information
Title:

CircRNA_ACAP2 Suppresses EMT in Head and Neck Squamous Cell Carcinoma by Targeting the miR-21-5p/STAT3 Signaling Axis.

Journal: Frontiers in oncology
Published: 2020
PubMed ID: 33363013
Study type:

combined biological and clinical study

Data availability: The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Code availability: -